Neste Oyj enters the final weeks before its October results with a sharp price recovery and a borrow market that remains remarkably relaxed — an unusual combination for a stock still nursing fresh earnings wounds.
The price story is the most striking feature of the week. Neste gained 5.3% on Tuesday alone and is up 1.4% across the week, now trading at €33.41. That continues a broader October-month rebound of nearly 10% — a meaningful reversal from the 11.3% single-day collapse that followed Q2 results in July, when the stock fell a further 9% over the subsequent five days. The recovery has pulled the share price roughly level with the analyst consensus price target of around €33.55, leaving almost no implied upside at current levels. That is worth noting before reading too much conviction into the rally.
The lending market tells a story of complete disinterest from short sellers. Borrow availability is exceptionally loose — over 2,380% of shares already borrowed are still available to lend, well above even the 52-week low-availability reading of roughly 1,161%. Cost to borrow sits near 0.81%, essentially unchanged from a week ago and barely above a standard equity general-collateral rate. The ORTEX short score has drifted lower over the past two weeks, from around 30.5 in early September to 28.7 now, confirming that short-side conviction has been fading rather than building. There is no squeeze dynamic, no borrowing pressure, and no sign of incremental short positioning ahead of the October print.
The Street view is one of cautious constructiveness sitting uneasily against a difficult earnings history. The factor score for analyst recommendation divergence ranks in the 91st percentile — meaning Neste is more positively rated relative to its own history than almost any peer in the universe. Dividend score ranks in the 90th percentile. Both EPS momentum measures are solid: the 30-day reading scores in the 78th percentile and the 90-day in the 72nd. Yet forward earnings growth ranks in only the 24th percentile, a reminder that the renewable fuels margin story has not yet delivered the acceleration bulls were pricing in. Valuation is neither cheap nor expensive: the trailing P/E is just under 12 and EV/EBITDA has compressed to 7.8 over the past month as the share price ran ahead of earnings revisions. Peers have had a constructive week — REP gained 3.7% and FANG rose nearly 6% — so Neste's more modest weekly gain of 1.4% is a slight underperformance against energy names broadly.
The ownership structure reinforces the stock's defensive, state-anchored character. The Finnish state holds 44.3% of shares outstanding and has not changed its position. Finnish pension funds Ilmarinen and Varma together hold a further 6.2%. Active international flow has been more interesting: Capital Research added 540,000 shares through June, Norges Bank added 227,000 through the same month, and Amundi added over a million shares through August — all modest in context but collectively pointing to steady accumulation from global institutions at levels well below the current price. Eleva Capital disclosed a fresh 3.6 million-share position as of end-June, a new entry worth watching as a conviction signal from a concentrated European equity manager.
The next event that matters is the Q3 earnings release on October 29. Given the Q2 experience — where a double-digit fall followed in a single session and losses extended through the following week — the question going into that print is whether the recovery in refinery margins and sustainable aviation fuel volumes flagged in early September commentary translates into numbers that justify a stock now trading back near consensus target.
See the live data behind this article on ORTEX.
Open NESTE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.